About the Authors
- Bernhard Scheicher
-
Affiliation Department of Pharmaceutical Technology, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria
- Cornelia Lorenzer
-
Affiliation Department of Pharmaceutical Technology, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria
- Katrin Gegenbauer
-
Affiliation Department of Pharmaceutical Technology, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria
- Julia Partlic
-
Affiliation Department of Pharmaceutical Technology, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria
- Fritz Andreae
-
Affiliation piCHEM, Kahngasse 20, Graz, Austria
- Alexander H. Kirsch
-
Affiliation Department of Internal Medicine, Clinical Division of Nephrology, Medical University of Graz, Auenbruggerplatz 27, Graz, Austria
- Alexander R. Rosenkranz
-
Affiliation Department of Internal Medicine, Clinical Division of Nephrology, Medical University of Graz, Auenbruggerplatz 27, Graz, Austria
- Oliver Werzer
-
Affiliation Department of Pharmaceutical Technology, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria
- Andreas Zimmer
-
* E-mail: andreas.zimmer@uni-graz.at
Affiliation Department of Pharmaceutical Technology, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria
Competing Interests
Dr. Fritz Andreae is the owner and CEO of piCHEM. piCHEM manufactured the peptides used in this study. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: FA AZ. Data curation: BS. Formal analysis: BS. Investigation: BS CL KG JP. Methodology: BS AHK OW. Project administration: AZ. Resources: ARR AHK OW AZ. Supervision: ARR AZ. Visualization: BS AZ. Writing – original draft: BS. Writing – review & editing: FA AZ.